1. Risk of venous thromboembolism in the antepartum and postpartum period was comparable between the intermediate- and low-dose low-molecular weight ...
1. In this random1. In this randomized controlled trial that included 9711 patients undergoing hip or knee arthroplasty, treatment ...
1. Patients hospitalized due to COVID-19 had a higher risk of developing a venous thromboembolism within 90 days of admission ...
1. In a large longitudinal, population-based cohort study, SARS-CoV-2 infection during pregnancy was associated with severe maternal morbidity, preterm birth, ...
1. The primary efficacy outcome of symptomatic and asymptomatic venous thromboembolism was significantly lower in the rivaroxaban group (3.14%) compared ...
1. There was no significant difference in all-cause mortality and need for invasive mechanical ventilation among patients assigned to aspirin ...
1. The primary efficacy outcome of symptomatic and asymptomatic venous thromboembolism was significantly lower in the rivaroxaban group (3.14%) compared ...
1. In patients treated with direct oral anticoagulants (DOACs) for atrial fibrillation or venous thromboembolism (VTE), adding aspirin (ASA) was ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.